{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:48:28Z","timestamp":1758268108669,"version":"3.44.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Establishment and validation of Nomogram model for individualized prediction of moderate to severe skin toxicity risk caused by fruquintinib in patients with advanced colorectal cancer.","award":["2023AH050834"],"award-info":[{"award-number":["2023AH050834"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>In the clinical management of advanced colorectal cancer, traditional Chinese patent medicines or their simple preparations are commonly combined with conventional chemotherapy; however, robust comparative evidence on efficacy and safety across regimens is lacking. Because the submission system does not allow relabeling the section heading, we have clarified this change here.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Randomized controlled trials investigating the use of traditional Chinese patent medicines and simple preparations in combination with conventional chemotherapy for the treatment of advanced colorectal cancer were searched in the following databases: CNKI, Wanfang, VIP, PubMed, Cochrane Library, Embase, and Web of Science. The search was conducted from the establishment of the databases until October 20, 2023, using computer-based searches. Two individuals independently screened, extracted data, and assessed the quality of the literature. Used RevMan and Stata 16.0 software to analyze the data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 45 studies were included, involving 3888 patients with advanced colorectal cancer. The intervention measures in the experimental group included Huachansu capsules, Brucea Javanica Oil Emulsion injection, Kanglaite, Xiaoaiping, compound cantharidin capsules, Kangai injection, Yangzheng Xiaoji capsules, Tenglong Buzhong Tang, Aidi injection, and Compound Sophora flavescens injection, in combination with conventional chemotherapy. The control group was treated with conventional chemotherapy. The mesh meta-analysis results showed that the combination of conventional chemotherapy has the following benefits for colorectal cancer patients: Yangzheng Xiaoji capsule is the best in terms of improving the objective response rate (ORR), disease control rate (DCR), quality of life (QOL), and immune function. Huachansu capsule is the best in terms of reducing the decline of white blood cell count and the incidence of nausea and vomiting after chemotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The existing evidence indicates that the combination of 10 traditional Chinese patent medicines and simple preparations, in addition to conventional chemotherapy, can improve the DCR, ORR, and QOL for patients with advanced colorectal cancer. Furthermore, this combination treatment can improve patients\u2019 immune function and reduce the adverse reactions associated with chemotherapy. Among them, Yangzheng Xiaoji capsules have the best effect in improving immune function, ORR, DCR, and QOL, Huachansu capsules have the best effect in improving white blood cell count decline and reducing nausea and vomiting after chemotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043147","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:02:15Z","timestamp":1754089335000},"page":"e43147","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Beneficial effects of proprietary Chinese medicines as adjuvant therapy in patients with advanced colorectal cancer: A meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3749-836X","authenticated-orcid":false,"given":"Mingxing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Lu\u2019an Hospital of Traditional Chinese Medicine Affiliated to Anhui University of Chinese Medicine, Lu\u2019an, Anhui Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3667-6236","authenticated-orcid":false,"given":"Wanhui","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Lu\u2019an Hospital of Traditional Chinese Medicine Affiliated to Anhui University of Chinese Medicine, Lu\u2019an, Anhui Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingming","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Lu\u2019an Hospital of Traditional Chinese Medicine Affiliated to Anhui University of Chinese Medicine, Lu\u2019an, Anhui Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongyi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Lu\u2019an Hospital of Traditional Chinese Medicine Affiliated to Anhui University of Chinese Medicine, Lu\u2019an, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer.","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer.","volume":"15","author":"Weng","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"R4-20250918","first-page":"47","article-title":"Study on the compound cantharis injection TGF-beta1 expression in patients with locally advanced colorectal cancer.","volume":"39","author":"Bingxin","year":"2016","journal-title":"J Yunnan Univ Tradit Chin Med"},{"key":"R5-20250918","first-page":"21","article-title":"Analysis on medication rules of using Chinese medicine in reducing recurrence and metastasis of stage II and III colorectal cancer among postoperative patients.","volume":"16","author":"Xin","year":"2014","journal-title":"Mod Tradit Chin Med Materia Medica"},{"key":"R6-20250918","first-page":"60","article-title":"Pharmacological molecular mechanism of banmao(mylabris) based on bioinformatics and system pharmacology.","volume":"25","author":"Miao-Fen","year":"2019","journal-title":"Guiding J Tradit Chin Med Pharm"},{"key":"R7-20250918","first-page":"4343","article-title":"Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells.","volume":"16","author":"Lu","year":"2018","journal-title":"Oncol Lett"},{"key":"R8-20250918","first-page":"28","article-title":"Curative effect of cinobufotalin capsule combined with FOLFOX4 regimen on advanced colon cancer.","volume":"20","author":"Zhanguo","year":"2019","journal-title":"Pract Clin Med"},{"key":"R9-20250918","first-page":"27","article-title":"Observation on the clinical efficacy of cinobufotalin combined with chemotherapy in the treatment of advanced colon cancer.","volume":"34","author":"Miao","year":"2018","journal-title":"Chin Community Doctors"},{"key":"R10-20250918","first-page":"1560","article-title":"Clinical effect of cinobufotalin capsule combined with XELOX chemotherapy on treatment of advanced colorectal cancer.","volume":"29","author":"Jinpeng","year":"2017","journal-title":"Med J West China"},{"key":"R11-20250918","first-page":"1078","article-title":"Efficacy of cinobufacini capsule combined with chemotherapy for stage III colorectal carcinoma after surgery.","volume":"24","author":"Yan-jiang","year":"2017","journal-title":"Chin J Clin Oncol Rehabil"},{"key":"R12-20250918","first-page":"9","article-title":"Evaluation of the efficacy of cinobufotalin capsule in adjuvant treatment of advanced colorectal cancer.","volume":"21","author":"Hui","year":"2014","journal-title":"Chin J Rural Med Pharm"},{"key":"R13-20250918","first-page":"91","article-title":"Application effect of Huachansu tablets in chemotherapy for postoperative patients with colorectal cancer.","volume":"27","author":"Ming-wei","year":"2020","journal-title":"China Mod Med"},{"key":"R14-20250918","first-page":"1177","article-title":"Curative effect of Cavenzi Oil Emulsion injection combined with capecitabine in the treatment of advanced colorectal cancer.","volume":"25","author":"Youwei","year":"2018","journal-title":"Clin Med Eng"},{"key":"R15-20250918","first-page":"156","article-title":"Efficacy analysis of Brucea javanica oil emulsion combined with capecitabine in treatment of advanced colorectal cancer.","volume":"19","author":"Ting-ting","year":"2014","journal-title":"Mod Interv Diagn Treat Gastroenterol"},{"key":"R16-20250918","first-page":"56","article-title":"Curative effect of Brucea javanica oil emulsion injection combined with folfox4 regimen on advanced colon cancer patients.","volume":"14","author":"Hongxia","year":"2012","journal-title":"Chin Community Doctors"},{"key":"R17-20250918","first-page":"33","article-title":"Clinical observation of Brucea javanica oil emulsion injection combined with chemotherapy in the treatment of advanced colorectal cancer.","volume":"25","author":"Jing","year":"2019","journal-title":"Contemp Med"},{"key":"R18-20250918","first-page":"2640","article-title":"Clinical efficacy and possible mechanism of Brucea javanica oil emulsion injection on patients with colorectal cancer.","volume":"39","author":"Mengyan","year":"2016","journal-title":"J Chin Med Mater"},{"key":"R19-20250918","first-page":"16","article-title":"FOLFOX6 regimen combined with bruceolic oil emulsion in the treatment of metastatic large intestine carcinoma.","volume":"26","author":"Qiyun","year":"2013","journal-title":"J Basic Clin Oncol"},{"key":"R20-20250918","first-page":"9","article-title":"XELOX schema combined with Kanglete injection in the treatment of late colonic cancer: effect observation on 46 cases.","volume":"42","author":"Wen-qun","year":"2022","journal-title":"Chin J Coloproctol"},{"key":"R21-20250918","first-page":"20377","article-title":"Evaluation of Kanglaite combined with S-1 in the treatment of elderly patients with advanced colorectal cancer.","volume":"4","author":"Tao","year":"2017","journal-title":"Electron J Clin Med Lit"},{"key":"R22-20250918","first-page":"377","article-title":"Short term efficacy of combination of oxaliplatin, capecitabine and Kanglaite in the treatment of advanced colorectal carcinoma.","volume":"24","author":"Xiaoda","year":"2011","journal-title":"Med Inform"},{"key":"R23-20250918","first-page":"1178","article-title":"The clinical observation of Kanglaite injection combined with S-1 in the treatment of recurrent or metastatic colorectal cancer.","volume":"16","author":"Lu","year":"2018","journal-title":"Oncol Prog"},{"key":"R24-20250918","first-page":"480","article-title":"Clinical analysis of Xiaoaiping combined with docetaxel and cisplatin in the treatment of advanced colon cancer.","volume":"26","author":"Ke","year":"2021","journal-title":"Mod Interv Diagn Treat Gastroenterol"},{"key":"R25-20250918","first-page":"1025","article-title":"Study of Xiaoaiping combined with XELOX chemotherapy intervention of immune function of patients with colorectal cancer after operation.","volume":"27","author":"Pei","year":"2015","journal-title":"Med J West China"},{"key":"R26-20250918","first-page":"1831","article-title":"Clinical efficacy of Xiaoaiping injection as retention enema in the treatment of colorectal cancer.","volume":"12","author":"Fan","year":"2014","journal-title":"Chin J Gen Pract"},{"key":"R27-20250918","first-page":"55","article-title":"Clinical study of Xiaoaiping combined with XELOX regimen in the treatment of advanced colorectal cancer.","volume":"10","author":"Yantao","year":"2013","journal-title":"J North Pharm"},{"key":"R28-20250918","first-page":"14","article-title":"Xiaoaiping injection combined with FOLFOX4 regimen in the treatment of 40 cases of advanced colon cancer.","volume":"25","author":"Ling","year":"2012","journal-title":"Tradit Chin Med Res"},{"key":"R29-20250918","first-page":"165","article-title":"Clinical efficacy of compound cantharis capsule combined with modified mFOLFOX6 chemotherapy in treatment of advanced colon cancer and its effect on cellular immune function.","volume":"40","author":"Youguo","year":"2022","journal-title":"Chin Arch Tradit Chin"},{"key":"R30-20250918","first-page":"188","article-title":"Effect of compound cantharidin capsule combined with teggio monotherapy on advanced colorectal cancer and its effect on levels of CEA, VEGF and CA199.","volume":"39","author":"Sumei","year":"2021","journal-title":"Chin Arch Tradit Chin"},{"key":"R31-20250918","first-page":"1759","article-title":"Clinical study on compound banmao capsules combined with FOLFOX6 chemotherapy in treatment of elderly hepatic metastasis of colonic carcinoma.","volume":"32","author":"Guang-cai","year":"2017","journal-title":"Drugs Clin"},{"key":"R32-20250918","first-page":"1431","article-title":"Clinical observation of compound blister beetle capsule combined with chemotherapy for patients after radical resection of rectal cancer.","volume":"44","author":"Huijun","year":"2017","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R33-20250918","first-page":"706","article-title":"Effect of Kang\u2019ai injection combined with oxaliplatin and capecitabine chemotherapy on patients with colon cancer.","volume":"17","author":"Qirong","year":"2022","journal-title":"China Med"},{"key":"R34-20250918","first-page":"83","article-title":"Effect of Kangai injection combined with chemotherapy on advanced colon cancer and its influence on serum CYFRA21-1 and CEA levels.","volume":"14","author":"Il-ming","year":"2021","journal-title":"Chin J Clin Ration Drug Use"},{"key":"R35-20250918","first-page":"88","article-title":"Effect of Kangai injection combined with CapeOX chemotherapy regimen on serum CYFRA21-1, CEA levels and quality of life in patients with advanced colon cancer.","volume":"37","author":"Hao","year":"2019","journal-title":"J Prev Med Chin PLA"},{"key":"R36-20250918","first-page":"429","article-title":"Effects of Kang\u2019ai injection on immunomodulation and long-term clinical outcome in patients with stage II Bor III colon cancer.","volume":"33","author":"Bin","year":"2018","journal-title":"J Pract Oncol"},{"key":"R37-20250918","first-page":"1586","article-title":"Clinical study on chemotherapy combined with Yangzheng Xiaoji capsule in treatment of advanced colorectal cancer.","volume":"32","author":"Bo","year":"2017","journal-title":"Acta Chin Med"},{"key":"R38-20250918","first-page":"52","article-title":"Combination of \u201cYangzheng Xiaoji capsule\u201d and chemotherapy for the treatment of advanced colon and rectal cancer: a report of 160 cases.","volume":"47","author":"Jiahe","year":"2013","journal-title":"Shanghai J Tradit Chin Med"},{"key":"R39-20250918","first-page":"3044","article-title":"Efficacy and safety of Yangzhengxiaoji capsule in adjuvant treatment of advanced colon cancer.","volume":"25","author":"Yan","year":"2016","journal-title":"Mod J Integr Tradit Chin Western Med"},{"key":"R40-20250918","first-page":"868","article-title":"Clinical study on Yangzheng Xiaoji capsules combined with FOLFIRI scheme in treatment of colorectal cancer.","volume":"31","author":"Yong-qing","year":"2016","journal-title":"Drugs Clin"},{"key":"R41-20250918","first-page":"37","article-title":"Clinical trial of Tenglong Buzhong decoction plus chemotherapy for metastatic colorectal cancer.","volume":"33","author":"Bing","year":"2015","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R42-20250918","first-page":"1414","article-title":"Clinical effect of Aidi injection combined with FOLFIRI program in treatment of advanced colorectal cancer.","volume":"13","author":"Gang","year":"2015","journal-title":"Chin J Gen Pract"},{"key":"R43-20250918","first-page":"1473","article-title":"Effect of Addie injection combined with FOLFIRI regimen in treatment of advanced colorectal cancer.","volume":"34","author":"Youlin","year":"2016","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R44-20250918","first-page":"946","article-title":"Clinical observation of Aidi injection combined with FOLFIR in the treatment of end-stage colorectal cancer.","volume":"21","author":"Xueyuan","year":"2012","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"R45-20250918","first-page":"397","article-title":"Objective to evaluate the efficacy of Aidi combined with chemotherapy in the treatment of end-stage colorectal cancer.","volume":"21","author":"Zhen","year":"2011","journal-title":"Zhejiang J Integr Tradit Chin West Med"},{"key":"R46-20250918","first-page":"73","article-title":"Objective to evaluate the safety and efficacy of Aidi injection combined with FOLFIR in the treatment of end-stagecolorectal cancer.","volume":"11","author":"Mingquan","year":"2018","journal-title":"Chin J Clin Ration Drug Use"},{"key":"R47-20250918","first-page":"391","article-title":"Clinical efficacy and survival analysis of compound Kushen injection combined with FOLFOX4 in the treatment of 78 patients with advanced colorectal cancer.","volume":"12","author":"Weizhi","year":"2022","journal-title":"Anti-Tumor Pharm"},{"key":"R48-20250918","first-page":"9","article-title":"Compound Kushen injection combined with chemotherapy of FOLFOX4 scheme in the treatment of late colorectal cancer following surgery.","volume":"41","author":"Zhen-tao","year":"2021","journal-title":"Chin J Coloproctol"},{"key":"R49-20250918","first-page":"108","article-title":"The effect of complex Sophorae injection on Th17 cells and IL-17 in patients with rectal cancer and its long-term clinical efficacy.","volume":"25","author":"Tie-bin","year":"2017","journal-title":"Chin J Integr Tradit West Med Dig"},{"key":"R50-20250918","first-page":"173","article-title":"Clinical observation of compound radix sophora flavescentis injection combined with FOLFOX4 regimen in the treatment of advanced colorectal cancer.","volume":"10","author":"Zhihua","year":"2016","journal-title":"Chin J Mod Drug Appl"},{"key":"R51-20250918","first-page":"3488","article-title":"Observation on the curative effect of compound Sophora flavescens injection combined with oxaliplatin in the treatment of rectal cancer.","volume":"24","author":"Qing","year":"2015","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"R52-20250918","first-page":"1652","article-title":"Clinical observation of IMRT therapy combined with astragalus polysaccharide injection on cervicocerebral tumor treatment.","volume":"30","author":"Dan-dan","year":"2014","journal-title":"J Pract Med"},{"key":"R53-20250918","first-page":"129","article-title":"Anti-tumor effects of astragaloside IV: research progress study.","volume":"36","author":"Qiao","year":"2019","journal-title":"Inform Tradit Chin Med"},{"key":"R54-20250918","first-page":"427","article-title":"Advances of ginsenosides in anticancer activities.","volume":"28","author":"Kai","year":"2015","journal-title":"J Med Res Combat Trauma Care"},{"key":"R55-20250918","first-page":"1104","article-title":"Research progress on chemical constituents of Hedyotis diffusa Willd and its pharmacological activities.","volume":"34","author":"Liang","year":"2017","journal-title":"J Shenyang Pharm Univ"},{"key":"R56-20250918","first-page":"37","article-title":"Research progress on pharmacological effects and clinical applications of Cynanchum paniculatum.","volume":"31","author":"Xue","year":"2017","journal-title":"Chem Ind Times"},{"key":"R57-20250918","first-page":"152","article-title":"Advances in studies on immunomodulating and anti-tumor effects of Ganoderma lucidum.","volume":"29","author":"Gaoqiang","year":"2010","journal-title":"Mycosystema"},{"key":"R58-20250918","first-page":"336","article-title":"Inhibition of Astragalus membranaceus, Curcuma and its compatibility on lung metastases in Lewis tumor-bearing mice through influencing tumor epithelial-mesenchymal transition.","volume":"38","author":"Cheng-yong","year":"2019","journal-title":"Beijing J Tradit Chin Med"},{"key":"R59-20250918","first-page":"3757","article-title":"Recent clinical and experimental studies on Yangzhengxiaoji capsule in treating malignant tumors.","volume":"24","author":"Junfang","year":"2015","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"R60-20250918","first-page":"59","article-title":"Efficacy and safety of Yangzhengxiaoji capsule combined with chemotherapy for malignant digestive tract tumor: a meta-analysis.","volume":"18","author":"Lishuang","year":"2018","journal-title":"Chin J Evid Based Med"},{"key":"R61-20250918","first-page":"192","article-title":"Progress in antitumor effect and mechanism of Cinobufagin.","volume":"37","author":"Hong-lei","year":"2021","journal-title":"Chin J Clin Pharmacol"},{"key":"R62-20250918","first-page":"385","article-title":"Research progress in the mechanism of antineoplastic action of Huachansu.","volume":"15","author":"Zi-jian","year":"2020","journal-title":"World J Integr Tradit West Med"},{"key":"R63-20250918","first-page":"2737","article-title":"Research progress on anti-tumor mechanisms and adverse reactions of Cinobufagin.","volume":"26","author":"Qiu-wen","year":"2015","journal-title":"Lishizhen Med Materia Medica Res"},{"key":"R64-20250918","first-page":"779","article-title":"Cinobufotalin combined with chemotherapy for the advanced gastrointestinal cancer: a meta-analysis.","volume":"25","author":"Likai","year":"2016","journal-title":"Chin J Gastroenterol Hepatol"},{"key":"R65-20250918","first-page":"52","article-title":"Clinical observation of cinobufotalin combined with chemotherapy in the treatment of advanced intestinal cancer.","volume":"20","author":"Yun","year":"2013","journal-title":"Chin J Rural Med Pharm"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:01:32Z","timestamp":1758232892000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":65,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043147","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}